Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:0
  • preuzimanja u poslednjih 30 dana:0
članak: 10 od 32  
Back povratak na rezultate
Vojnosanitetski pregled
2015, vol. 72, br. 7, str. 608-613
jezik rada: engleski
vrsta rada: izvorni naučni članak
doi:10.2298/vsp140622066M
Klinički značaj nivoa rastvorljivog Fas u plazmi kod bolesnika sa sepsom
aClinic for Infectious and Tropical Diseases, Military Medical Academy, Belgrade + Faculty of Medicine of the Military Medical Academy, University of Defence, Belgrade
bFaculty of Medicine of the Military Medical Academy, University of Defence, Belgrade + Institute of Medical Research, Military Medical Academy, Belgrade
cVojnomedicinska akademija
dFaculty of Medicine of the Military Medical Academy, University of Defence, Belgrade

e-adresa: drmikic@gmail.com

Sažetak

Uvod/Cilj. Cilj savremenih kliničkih i eksperimentalnih istraživanja u oblasti sepse je da se pronađe jedan ili više osetljivih parametara koji bi mogli da predvide težinu sepse i njen ishod. Cilj ovog rada bio je ispitivanje i upoređivanje odnosa početnih nivoa rastvorljivog Fas (sFas) u plazmi, kao i Acute Physiology, Age and Chronic Health Evaluation (APACHE) II skora sa težinom i ishodom sepse kod 58 bolesnika sa sepsom. Metode. Na osnovu kliničkih i laboratorijskih parametara istog dana postavljana je dijagnoza i vršena je procena težine bolesti. Iz uzoraka krvi određivani su standardni laboratorijski parametari potrebni za postavljanje dijagnoze sepse, disfunkcije organa i procenu težine bolesti, a, takođe, izmeren je i nivo sFas u plazmi. Prema konsenzus kriterijumima, bolesnici su podeljeni u grupe sa sepsom (n = 16), teškom sepsom (n = 30) ili septičkim šokom (n = 12), grupe sa (n = 26) i bez (n = 32) sindroma multiorganske disfunkcije (multiple organ dysfunction syndrome - MODS), i na preživele (n = 45) i bolesnike sa smrtnim ishodom (n = 13). Rezultati. Povišene nivoe sFas u plazmi (9,7 ± 10,1; 0-44.2 U/mL) imalo je 54,4% bolesnika, i to svi bolesnici sa septičkim šokom, 76,9% bolesnika sa MODS i 84,6% bolesnika sa smrtnim ishodom. Utvrđena je značajna pozitivna korelacija nivoa sFas u plazmi i APACHE II skora (p < 0,001). Bolesnici sa septičkim šokom imali su značajno više prosečne nivoe sFas u odnosu na normotenzivne bolesnike (p < 0.001). Značajno viši nivoi sFas utvrđeni su kod bolesnika sa MODS nego kod bolesnika bez MODS (p < 0.001 ), a značajno niži kod preživelih nego kod bolesnika sa smrtnim ishodom (p < 0.01). Zaključak. Početni nivoi sFas u plazmi kod bolesnika sa sepsom pozitivno korelišu sa vrednostima APACHE II skora i međusobno se razlikuju između bolesnika sa septičkim šokom i normotenzivnih bolesnika, bolesnika sa i bez MODS, kao i između preživelih i bolesnika sa smrtnim ishodom.

Ključne reči

Reference

Abbas, A.K., Lichtman, A.H., Pober, J.S. (2000) Apoptosis in lymphocytes. u: Cellular and molecular immunology, Philadelphia, Pensilvania: WB Saunders Company. The Curtis Center, str. 220-222
Abello, P.A., Fidler, S.A., Bulkley, G.B., Buchman, T.G. (1994) Antioxidants modulate induction of programmed endothelial cell death (apoptosis) by endotoxin. Arch Surg, 129(2): 134-40; discussion 140-1
Angus, D.C., van der Poll, T. (2013) Severe sepsis and septic shock. N Engl J Med, 369(9): 840-51
Ayala, A., Herdon, C.D., Lehman, D.L., Ayala, C.A., Chaudry, I.H. (1996) Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood, 87(10): 4261-75
Ayala, A., Chung, C.S., Xu, Y.X., Evans, T.A., Redmond, K.M., Chaudry, I.H. (1999) Increased inducible apoptosis in CD4+ T lymphocytes during polymicrobial sepsis is mediated by Fas ligand and not endotoxin. Immunology, 97(1): 45-55
Ayala, A., Xu, Y.X., Chung, C.S., Chaudry, I.H. (1999) Does Fas ligand or endotoxin contribute to thymic apoptosis during polymicrobial sepsis?. Shock, 11(3): 211-7
Ayala, A., Xin, X.Y., Ayala, C.A., Sonefeld, D.E., Karr, S.M., Evans, T.A., Chaudry, I.H. (1998) Increased mucosal B-lymphocyte apoptosis during polymicrobial sepsis is a Fas ligand but not an endotoxin-mediated process. Blood, 91(4): 1362-72
Ayala, A., Chung, C.S., Song, G.Y., Chaudry, I.H. (2001) IL-10 mediation of activation-induced TH1 cell apoptosis and lymphoid dysfunction in polymicrobial sepsis. Cytokine, 14(1): 37-48
Bone, R.C., Balk, R.A., Cerra, F.B., Dellinger, R.P., Fein, A.M., Knaus, W.A., Schein, R.M., Sibbald, W.J. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: The ACCP/SCCM Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine. Chest, 101(6): 1644-55
Brown, K.A., Brain, S.D., Pearson, J.D., Edgeworth, J.D., Lewis, S.M., Treacher, D.F. (2006) Neutrophils in development of multiple organ failure in sepsis. Lancet, 368(9530): 157-169
Cascino, I., Fiucci, G., Papoff, G., Ruberti, G. (1995) Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J Immunol, 154(6): 2706-13
Cheng, J., Zhou, T., Liu, C., Shapiro, J.P., Brauer, M.J., Kiefer, M.C., Barr, P.J., Mountz, J.D. (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science, 263(5154): 1759-62
Clark, A.M., Plank, D.L., Connolly, A.B., Streat, J.S., Hill, A.A., Gupta, R., i dr. (1998) Effect of a chimeric antibody to tumor necrosis factor-alfa on cytokine and physiologic responses in patients with severe sepsis: A randomized, clinical trial. Crit Care Med, 26(10), str. 1650-9
de Freitas, I., Fernández-Somoza, M., Essenfeld-Sekler, E., Cardier, J.E. (2004) Serum levels of the apoptosis-associated molecules, tumor necrosis factor-alpha/tumor necrosis factor type-I receptor and Fas/FasL, in sepsis. Chest, 125(6): 2238-46
Dellinger, R.P., Levy, M.M., Rhodes, A., Annane, D., Gerlach, H., Opal, S.M. (2012) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med, 41(2): 580-637
Endo, S., Inada, K., Takakuwa, T., Kasai, T., Yamada, Y., Wakabayashi, G., Niimi, M., Suzuki, T., Taniguchi, S. (1996) Nitrite/nitrate (NOx) and sFas antigen levels in patients with multiple organ failure. Res Commun Mol Pathol Pharmacol, 92(2): 253-6
Fanning, N.F., Kell, M.R., Shorten, G.D., Kirwan, W.O., Bouchier-Hayes, D., Cotter, T.G., Redmond, H.P. (1999) Circulating granulocyte macrophage colony-stimulating factor in plasma of patients with the systemic inflammatory response syndrome delays neutrophil apoptosis through inhibition of spontaneous reactive oxygen species generation. Shock, 11(3): 167-74
Fleck, M., Reng, M., i dr. (2000) USA. Significantly elevated levels of soluble Fas(CD95/APO-1) in sera of septic patients. str. 461-463
Gustot, T. (2011) Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Curr Opin Crit Care, 17(2): 153-9
Hashimoto, S., Kobayashi, A., Kooguchi, K., Kitamura, Y., Onodera, H., Nakajima, H. (2000) Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Am J Respir Crit Care Med, 161(1): 237-43
Hotchkiss, R.S., Swanson, P.E., Freeman, B.D., Tinsley, K.W., Cobb, J.P., Matuschak, G.M., Buchman, T.G., Karl, I.E. (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med, 27(7): 1230-51
Huttunen, R., Syrjänen, J., Vuento, R., Laine, J., Hurme, M., Aittoniemi, J. (2012) Apoptosis markers soluble Fas (sFas), Fas Ligand (FasL) and sFas/FasL ratio in patients with bacteremia: a prospective cohort study. J Infect, 64(3): 276-81
Kaukonen, K., Bailey, M., Suzuki, S., Pilcher, D., Bellomo, R. (2014) Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA, 311(13): 1308-16
Keel, M., Ungethüm, U., Steckholzer, U., Niederer, E., Hartung, T., Trentz, O., Ertel, W. (1997) Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood, 90(9): 3356-63
Knaus, W.A., Draper, E.A., Wagner, D.P., Zimmerman, J.E. (1985) APACHE II: A severity of disease classification system. Crit Care Med, 13(10): 818-29
Kumar, A., Zarychanski, R., Light, B., Parrillo, J., Maki, D., Simon, D., Laporta, D., Lapinsky, S., Ellis, P., Mirzanejad, Y., Martinka, G., Keenan, S., Wood, G., Arabi, Y., Feinstein, D., Kumar, A. (2010) Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis. Crit Care Med, 38(9): 1773-85
Ma, Y., Ye, F., Lv, W., Cheng, Q., Chen, H., Xie, X. (2008) Correlation between soluble Fas level and apoptosis of T cells in ovarian carcinoma. European Journal of Obstetrics & Gynecology and Reproductive Biology, 138(2): 204-211
Marshall, J.C., Watson, R.W.G. (1997) Apoptosis in the resolution of systemic inflammation. u: Vincent J.I. [ur.] Yearbook of intensive care and emergency medicine, New York: Springer, str. 100-108
Martin, G.S. (2012) Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther, 10(6): 701-6
Matute-Bello, G., Liles, W.C., Radella, F., Steinberg, K.P., Ruzinski, J.T., Hudson, L.D., Martin, T.R. (2000) Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome. Crit Care Med, 28(1): 1-7
Mikic, D. (2003) The monograph - Proinflammatory cytokines in sepsis and septic shock. Belgrade: Publisher Andrejevic Foundation
Mikic, D., Vasilijic, S., Maravic, V., Colic, M. (2006) Relationship between plasma levels of procalcitonin, tumor necrosis factor-α and C-reactive protein and clinical characteristic of septic patients. Clinical Application of Immunology, 5(1): 556-562
Oberholzer, C., Oberholzer, A., Clare-Salzler, M., Moldawer, L.L. (2001) Apoptosis in sepsis: a new target for therapeutic exploration. FASEB J, 15(6): 879-92
Papathanassoglou, E.D., Moynihan, J.A., Ackerman, M.H. (2000) Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? a review and a theoretical framework. Crit Care Med, 28(2): 537-49
Papathanassoglou, E.D., Moynihan, J.A., McDermott, M.P., Ackerman, M.H. (2001) Expression of Fas (CD95) and Fas ligand on peripheral blood mononuclear cells in critical illness and association with multiorgan dysfunction severity and survival. Crit Care Med, 29(4): 709-18
Papathanassoglou, E.D., Moynihan, J.A., Vermillion, D.L., McDermott, M.P., Ackerman, M.H. (2000) Soluble fas levels correlate with multiple organ dysfunction severity, survival and nitrate levels, but not with cellular apoptotic markers in critically ill patients. Shock, 14(2): 107-12
Papathanassoglou, E.D.E., Movnihan, J.A., Dafni, O., Mantzoros, C.S., Ackerman, M.H. (2003) Association of proinflammatory molecules with apoptotic markers and survival in critically ill multiple organ dysfunction patients. Biol Res Nurs, 5(2): 129-41
Park, D.R., Thomsen, A.R., Frevert, C.W., Pham, U., Skerrett, S.J., Kiener, P.A., Liles, C.W. (2003) Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J Immunol, 170(12): 6209-16
Paunel-Görgülü, A., Flohé, S., Scholz, M., Windolf, J., Lögters, T. (2011) Increased serum soluble Fas after major trauma is associated with delayed neutrophil apoptosis and development of sepsis. Critical Care, 15(1): R20, http://ccforum.com/content/15/1/R20
Savill, J. (1997) Apoptosis in resolution of inflammation. J Leukoc Biol, 61(4): 375-80
Shapiro, N.I., Trzeciak, S., Hollander, J.E., Birkhahn, R., Otero, R., Osborn, T.M., Moretti, E., Nguyen, H., Gunnerson, K.J., Milzman, D., Gaieski, D.F., Goyal, M., i dr. (2009) A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Critical care medicine, 37(1): 96-104
Siegel, R.M., Chan, F.K., Chun, H.J., Lenardo, M.J. (2000) The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol, 1(6): 469-74
Silvestris, F., Grinello, D., Tucci, M., Cafforio, P., Dammacco, F. (2003) Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-I) in active lupus. Lupus, 12(1): 8-14
Torre, D., Tambini, R., Manfredi, M., Mangani, V., Livi, P., Maldifassi, V., Campi, P., Speranza, F. (2003) Circulating levels of FAS/APO-1 in patients with the systemic inflammatory response syndrome. Diagn Microbiol Infect Dis, 45(4): 233-6
van Parijs, L., Abbas, A.K. (1996) Role of Fas-mediated cell death in the regulation of immune responses. Curr Opin Immunol, 8(3): 355-61
Vincent, J.L., Moreno, R., Takala, J., Willatts, S., de Mendonca, A., Bruining, H., Reinhart, C.K., Suter, P.M., Thijs, L.G. (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med, 22(7): 707-10
Wesche, D.E., Lomas-Neira, J.L., Perl, M., Chung, C., Ayala, A. (2005) Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol, 78(2): 325-37
Yasuda, N., Gotoh, K., Minatoguchi, S., Asano, K., Nishigaki, K., Nnomura, M., i dr. (1998) An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD. Respiratory Medicine, 92(8): 993-999
Zeerleder, S., Zwart, B., Wuilleman, W.A., Aarden, L.A., Groeneveld, A.B.J., Calisz, C., i dr. (2004) Apoptosis in Sepsis and Multiple Organ Dysfunction Syndrome. Advances in Critical Care Testing, str. 3-13